Avila granted sanofi exclusive, worldwide rights to develop and commercialize covalent cancer compounds discovered using Avila's Avilomics platform

Avila Therapeutics Inc.

U.S. / Private Biopharma

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

sanofi-aventis Group

France / Large-Cap Biopharma (>=$50 billion)

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced